Recent Finacing
Recent Raise
GLX Analytix develops a diagnostic platform combining glycocalyx biomarker assays with AI to enable early diagnosis, prediction, and longitudinal self-monitoring of autoimmune and neurodegenerative diseases.
Focus Areas
Recent Investors
Funding round
Investors
See the team members at GLX Analytix.
